Tags Posts tagged with "$EDXC"

$EDXC

0 1241

Endexx Enhances ‘Cannsumable’ Division With Revenue Generation and Distribution

CAVE CREEK, AZ–(Marketwired – Mar 25, 2015) – Endexx Corporation (OTC PINK: EDXC) a provider of innovative medical marijuana management and technology solutions, is pleased to announce the acquisition of CBD Health Solutions, LLC., a provider of nutraceutical and health related products in the “Phyto-Cannabinoid” arena. Endexx and CBD Health Solutions have been collaborating since September 2014, both test marketing and establishing supply chains and distribution channels utilizing Endexx’s base CBD delivery medium. CBD Health Solutions brings valuable industry experts in formulations, established industry distributors and products testers to our “Cannsumable” division. During their development and testing cycle they have formulated high quality products that fit perfectly with Endexx’s CBD initiative.

The website: www.cbdhealthsolutions.com has been live for three weeks and is generating impressive early stage sales of their current product line. Endexx’s CBDunlimited.com website, scheduled for release today, will be launched at the end of the month after fully integrating the back-end functionality of CBDhealthsolutions.com. The primary website for the “Cannsumable” division of Endexx is CBDunlimited.com. However, a full array of CBD products, applications and branding will be represented through multiple digital assets focusing on specific marketing platforms.

The CBD Health Solutions team has talent and resources that are critical to successfully implementing marketing strategies on multiple levels. The team has expertise in social media and digital advertising processes. Their target markets include: nationwide wholesale and retail distribution channels in vape shops, high end smoke shops and niche health and beauty care retailers. They are currently selling in ten states and expanding.

Scott Bramble, co-founder of CBD Health Solutions, stated “After working with Endexx for the past several months, it became apparent, through collaboration and combining our resources, we can execute our business strategy more efficiently. Together, our overall skill sets will provide us a competitive advantage in this rapidly evolving market.” Todd Davis, CEO of Endexx, added “CBD Health Solutions and their team are a high value acquisition for the long term success of Endexx in its effort to rapidly expand revenues and maximize shareholder value.”

About Endexx
Endexx provides innovative medical marijuana management and technology solutions. The Company has two products that launched in the first half of 2014 — the m3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub database is the first standardized software platform for tracking pharmaceutical grade marijuana to support a Centralized Medical Marijuana Industry Repository and maintain compliance with the laws of the federal government and state and local regulatory bodies. The Autospense™ is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. www.endexx.com, www.m3hub.com,www.facebook.com/EndexxCorporation, www.cbdhealthsolutions.com

Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

Contact:
CONTACT:
For further investor and media information
Endexx Corporation
Todd Davis
Chairman & CEO
endexx@endexx.com
480-595-6900

IRTH Communications
Robert Haag
Managing Director
edxc@irthcommunications.com
866-976-4784

0 2313

Endexx Corporation to Present at Cannabis Investor Webcast

Cave Creek, AZ / ACCESSWIRE / January 28, 2015 / Endexx Corporation (EDXC) is a micro-cap publicly traded company, collaborating with independent software developers, scientists, engineers, and other companies to build businesses. Endexx Corporation, will be a presenter at the upcoming Cannabis Investor Webcast on Thursday, January 29, 2015 at 3:00 PM EST.

“We’re excited that Endexx Corporation has decided to present to our online audience of industry investors, analysts, executives, media, and consumers,” said Derwin A. Wallace, Senior VP of Investor Webcast. “The online interactive webcast will assist Endexx Corporation in increasing its awareness and exposure.”

The Cannabis Investor Webcast will include presentations from privately-held and publicly-traded industry companies and professionals. Endexx Corporation’s presentation will be 30-minutes long and followed by 15-minutes of Q&A. The Cannabis Investor Webcast is a great opportunity for the audience to research industry companies without taking time-off from work, paying registration fees and incurring travel-related expenses.

“The Cannabis Investor Webcast is an online interactive platform that will assist us in updating the cannabis community about our accretive acquisitions and opportunities,” states Todd Davis, CEO of Endexx Corporation.

Cannabis investors, analysts, executives, media, and consumers who would like to attend our free online webcast please click on the link http://www.cannawebcast.com/ and visit the Registration Page and to view the recording of the webcast please click on this link Cannabis Investor Webcast Recordings two weeks after the presentation.

About Endexx

Endexx provides innovative medical marijuana management and technology solutions. The company has two technology products that launched in 2014 – the M3hub and the Autospense. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub database is the first standardized software platform for tracking pharmaceutical grade marijuana to support a Centralized Medical Marijuana Industry Repository and maintain compliance with the laws of State government and local regulatory bodies, as well as, provide a smooth transition to the eventual Federal mandates. The Autospense(TM) is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense(TM) increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. www.endexx.com, www.m3hub.com,www.autospense.com.

Contact:

Endexx Corporation
Todd Davis
Chairman & CEO
endexx@endexx.com
480-595-6900

0 1171

Endexx Announces Positive Results of Initial Diabetic Neuropathy Patient Study

CAVE CREEK, AZ–(Marketwired – Jan 28, 2015) – Endexx Corporation (OTC PINK: EDXC) announced today that phase 1 of a diabetic neuropathy case study with the purpose of observing if M3CBD, a uniquely formulated CBD and CBD-A rich industrial hemp extract would mitigate or alleviate pain when inhaled through an electronic vaporizer, has been successfully completed. The case study was initiated in late November 2014 by Dr. Daniel Kiddy, as a voluntary patient study.

Endexx provided its M3Vape starter kit to the study and food grade hemp oil extract from imported industrial hemp grown on a certified non-GMO eco-farm under strict organic practices. The batch used in the study was 100% natural and, free of all contaminants, pesticides, mold, bacteria and heavy metals. The hemp oil contained a rich blend of phytocannabinoids, including CBD, CBD-A, CBG, and CBC, and Citronellol, a powerful terpenoid, that together interact with cannabinoid receptors in what is known as the “entourage effect.”

Daniel Kiddy, DPM, compiled and documented preliminary results for phase 1 with the participation of thirteen volunteer patients, all of whom suffer from diabetic neuropathy. The participants administered a minimal dose of the oil through vaporizer inhalation three times a day. Results can be summarized as follows:

  • Of the thirteen volunteers who participated in the trial, five did not follow the dosage protocol and are excluded from the results.
  • Seven out of eight patients reported a decrease in pain level with improvements ranging from slight to as much as 75%, with one patient reporting being free of pain for the last 5 days of phase 1. One patient suffering from chronic migraine headaches reduced the use of prescribed pain medication (Sumatriptan) by 40%. Four patients stated improved sleep, feeling refreshed, energized or free of pain when waking up, while two patients experienced mood improvement, feeling happier and less depressed. One patient who experienced much improved sleep and reduced depression did not however experience any decrease in pain level. No patient reported adverse reactions.

The choice of electronic vaporizer as a patient friendly delivery system was prompted by CBD’s enhanced bioavailability and efficacy through inhalation. Cannabidiol has been shown in numerous human trials to be five times more bioavailable when inhaled than when taken orally.

While these results are purely anecdotal and only provide very limited and incomplete information that is in no way meant to be conclusive, they nevertheless supply critical feedback for doctors and patients alike and are designed to increase public awareness of the potential therapeutic and wellness properties of high grade, naturally occurring hemp extracts that are rich in cannabidiol and other phytocannabinoids. The trial is ongoing and seeks to add to a body of existing data and to inspire more wide scale research and encourage advanced clinical trials on the specific role of certain cannabinoids, including CBD in particular, in exerting significant analgesic effects in various chronic pain conditions, without psychoactive or adverse effects.

Dr. Kiddy stated: “Patients demonstrated significant reduction in pain and fatigue. Patients also experienced better sleep and more energy associated with use of the M3CBD oil. During the first thirty days, patients were instructed to use the product three times a day. Advancing into the second phase patients are instructed to increase to five times per day. As a result of this initial study, our expectations were exceeded in a very short period of time. We believe that ongoing studies and observations are warranted in order to establish a better understanding of the potential of this natural remedy.”

About Endexx
Endexx provides innovative medical marijuana management and technology solutions. The company has two technology products that launched in 2014 — the M3hub and the Autospense. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub database is the first standardized software platform for tracking pharmaceutical grade marijuana to support a Centralized Medical Marijuana Industry Repository and maintain compliance with the laws of State government and local regulatory bodies, as well as, provide a smooth transition to the eventual Federal mandates. The AutospenseTM is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. www.endexx.com, www.m3hub.com,www.autospense.com

1 1441

Endexx Provides Shareholder Update 2014/2015

CAVE CREEK, AZ–(Marketwired – Jan 6, 2015) – Endexx Corporation (OTC PINK: EDXC), a provider of innovative medical marijuana management and technology solutions, is pleased to provide a synopsis of 2014 and forward-looking initiatives for 2015.

While the medical and recreational marijuana industry is ever-changing and still in the nascent stages, creating standards for infrastructure and sustainability are the key drivers behind Endexx’s technology and service solutions. Collaborating with experts in multiple fields has produced pharmaceutical grade compliance and technology support platforms. The Company’s M3hub 1.0 core technology development has been completed. This system provides a compliant framework for tracking every asset, process, plant and human involved in the seed-to-sale life cycle of medical marijuana. Templates and collaboration with experts in growing and regulatory processes are being developed to provide turnkey solutions for regulators, administrators, growers and medical providers. Self-regulation and tracking are the two key elements for an industry to create its own standards. Left to officials, a red tape filled bureaucratic process will surely replace substandard compliance processes. Endexx’s systems provide solutions needed for this vibrant and sustainable growth industry. Moving forward, the M3hub’s future development will include integration of efficiency technologies like the Vuzix wearable computer interface, regulatory API protocols, and turnkey templates.

In 2014, Endexx entered into a collaboration agreement with Vicente & Sederberg, LLC., recently named by Denver’s monthly magazine, 5280, (partners Brian Vicente and Christian Sederberg) as two of the “Top Lawyers 2015″ in the category of Government Relations, Contracts, and Lobbying. The team at Vicente/Sederberg has provided Endexx with a transparent and legal pathway to validate their developed technologies, Autospense and M3hub, as potential standards in a rapidly changing legal environment.

First, Endexx has installed and prepared an Autospense (automated dispensing and inventory control) system at Pure Medical Dispensary in Colorado. Pure’s compliance and policy procedures are perfectly suited for testing the system in a transparent environment, inspected and regulated by the Marijuana Enforcement Division (MED) of Colorado. All labeling, packaging, tracking and receipt information protocols are being finalized by the entire team (Pure management, Vicente/Sederberg, and Endexx). Upon completion of this process, an inspection by the MED will be scheduled for further feedback and guidance to procure this critical stage in hopes of creating this as a standard in the medical marijuana industry.

Securing safe and high quality Cannabidiol (CBD) enriched oils and extracts was a significant challenge in 2014. Endexx still has concerns about all the legal processes involved in providing edible, food grade, CBD enriched industrial hemp oil products and is cautiously moving forward with all developments. Early reports, from the recently announced doctor-administered case study of diabetic neuropathy patients in the midwest, is revealing very encouraging reports. A preliminary anecdotal report is expected shortly. Sales on a small scale have been launched of the CBD enriched industrial hemp oil derivative. The customers are providing valuable feedback on all aspects of the product, packaging, delivery system, quality of product and its personal benefits to each individual. Endexx will be launching sales of its initial products in January. The frozen liquid products are entering the final stages of development. The organic flavors are excellent. Working with oil versus water soluble agents to produce organic grade products will determine which “Cannsumable” product will be launched first. Endexx’s policy is to provide the safest and highest quality products available. Testing of all products for all contaminants and percentages of bioactive nutrients is critical for both quality and safety and is adhered to on every batch and lot purchased.

Finally, Endexx announced in 2014, the beginning of its auditing process in preparation to becoming a fully reporting company and position itself for an up-listing in 2015. While the process has taken longer than originally expected, the exercise produced positive developments. In the recently released 10k annual report, the company showed its first revenue from its acquisition of Greenleaf Consulting, LLC. (a wholly owned division) and subsequently has secured significant new consulting contracts for fiscal 2015. While expenses did increase due to acquisitions, product development and investments, total equity improved by $891K to a positive $400K. Total liabilities were decreased by 10% and dilution was only increased by 6% (12.7 million common shares). In conjunction with the audit completing an S-1 and/or Form 10 will be filed with the SEC for both full reporting status and to enable the company to raise the necessary capital to execute the business plan and secure a long term acquisition strategy. As a result, we believe that Endexx is well positioned to generate significant growth and revenue in 2015 and 2016 during the industry’s march to legalization and transparency.

About Endexx Endexx provides innovative medical marijuana management and technology solutions. The Company has two products that launched in the first half of 2014 — the m3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub database is the first standardized software platform for tracking pharmaceutical grade marijuana to support a Centralized Medical Marijuana Industry Repository and maintain compliance with the laws of the federal government and state and local regulatory bodies. The Autospense™ is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers.www.endexx.com, www.m3hub.com, www.autospense.com

Safe Harbor Notice This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

Contact:
CONTACT:
For further investor and media information
Endexx Corporation
Todd Davis
Chairman & CEO
endexx@endexx.com
480-595-6900

IRTH Communications
Robert Haag
Managing Director
edxc@irthcommunications.com
866-976-4784

0 1202

Endexx Contributes to Diabetic Neuropathy Case Study

CAVE CREEK, AZ–(Marketwired – Dec 9, 2014) – Endexx Corporation (OTC PINK: EDXC) announced today that it is providing its CBD (Cannabidiol) starter kit (M3Vape) to a voluntary patient study utilizing industrial hemp oil that is rich in CBD/CBDa, as an application to potentially alleviate symptoms arising from diabetic neuropathy. Thirteen diabetic patients suffering from neuropathy in Missouri began a 30 day voluntary study in late November under the oversight of Dr. Daniel Kiddy, DPM. Dr. Kiddy stated, “The main objective for this short study is to simply see if pain is decreased or eliminated. We are also monitoring if the proprioception and sharp and dull sensation are improved.”

Endexx’s “Cannsumable” Division is developing two primary product lines derived from food grade and lab-tested industrial hemp oil. The oil is naturally rich in both CBD and CBDa phytocannabinoids. The industrial hemp is grown on a certified eco-farm under organic farming practices. The oil is extracted utilizing critical CO2 extraction processes. The oil is tested both at the manufacturing site and in the United States at a certified lab. The product has no heavy metals, pesticides, or other contaminants and is tested using microbiological methods for determining mold and bacteria levels.

Endexx is researching the highest quality sources of industrial hemp oil that achieves the following primary goals:
(i) The product must be safe.
(ii) The product must be legal under federal law.
(iii) The product must provide maximum bioavailability.
(iv) The product must be beneficial to the patient/consumer.

Consumer and patient safety is Endexx’s foremost concern.

This study is not an official clinical trial. The study will provide general feedback from patients anecdotally, providing information to the doctors, patients and providers of the product. Public awareness of cannabis and industrial hemp products containing therapeutic and wellness properties has escalated over the past few years, yet education and research is limited. Understanding the benefits and the negatives of any supplement or nutraceutical is critical when determining the direction of a product’s development and future use by the medical community and/or the general adult population.

About Endexx

Endexx provides innovative medical marijuana management and technology solutions. The company has two technology products that launched in 2014 — the M3hub and the Autospense. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub database is the first standardized software platform for tracking pharmaceutical grade marijuana to support a Centralized Medical Marijuana Industry Repository and maintain compliance with the laws of State government and local regulatory bodies, as well as, provide a smooth transition to the eventual Federal mandates. The AutospenseTM is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. Additionally, Endexx with its collaboration partners and consultants are developing two consumable product lines derived from industrial hemp that is organic and naturally rich in phytocannabinoids. Websites are: www.endexx.com,www.m3hub.com, www.autospense.com

Safe Harbor Notice

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

Contact:
For further investor and media information, contact:

Endexx Corporation
Todd Davis
Chairman & CEO
endexx@endexx.com
480-595-6900

and

Irth Communications
Robert Haag
Managing Director
edxc@irthcommunications.com
866-976-4784

 

0 1493

Endexx Launches Marijuana Dispensing Pilot Program in Colorado

Endexx Launches First Transparent Pilot and Testing Program for Medical Marijuana Dispensing With Autospense for High Security and Tracking

CAVE CREEK, AZ–(Marketwired – Dec 1, 2014) – Endexx Corporation (OTC PINK: EDXC), a provider of innovative medical marijuana management and technology solutions, announced today that the secured site location to test its Autospense™ technology is at Pure Medical Marijuana Dispensary on Colfax Ave. in Denver, Colorado. Pure was one of the first two dispensaries in 2009 to become a licensed dispensary in Colorado, and has served as a leader in the medical marijuana market for quality control, technology integration and compliance protocol. The 100-day pilot program is designed to test for compliance and tracking integration under the regulations set forth and enforced by the Marijuana Enforcement Division of Colorado. The pilot program also allows for collaboration in a live dispensary environment, to test technology and process integration for benefit of the dispensary owner and its patients and customers. The Autospense is installed and being calibrated this week for full time use.

Michael Quattrone of Pure Medical Dispensary stated, “In order to maintain top level quality control, transparency and compliance standards in this ever changing market, technology integration is key to sustainability and success. Endexx provides us a professional technology solution and a team that clearly has an objective to help set the standards for our industry. We are excited to participate in this critical and necessary pilot program.”

Endexx’s Autospense™ is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details, monitoring and tracking of inventory, and provides verification and safety for the product, as well as patients and customers of the dispensary. Autospense™ increases store productivity up to 10x and reduces operation costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers and provides patients and customers an option to make rapid purchases when they know what they want and are short on time.

“Lack of transparency and compliance can make dispensary owners vulnerable,” said Todd Davis, Founder and CEO of Endexx Corporation. “Regulatory compliance is essential for the long term sustainability of both the medical and retail marijuana markets. Autospense™ is ideal for any dispensary and offers a cutting-edge solution that maintains full compliance and has the ability to adapt with changing regulations. After extensively evaluating the barriers to adoption in an often-uncertain regulatory environment, Endexx chose to seek the most transparent and legal route before launching its product lines. Collaborating with a proven leader in the medical cannabis industry, Pure’s management team has offered us the perfect environment to execute our mission and test our compliance platform.”

About Endexx
Endexx provides innovative medical marijuana management and technology solutions. The company has two products that launched in 2014 — the M3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub database is the first standardized software platform for tracking pharmaceutical grade marijuana to support a Centralized Medical Marijuana Industry Repository and maintain compliance with the laws of State government and local regulatory bodies, as well as, provide a smooth transition to the eventual Federal mandates. The Autospense™ is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. www.endexx.com, www.m3hub.com, www.autospense.com

Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

Contact:
For further investor and media information, contact:
Endexx Corporation
Todd Davis
Chairman & CEO
endexx@endexx.com
480-595-6900

IRTH Communications
Robert Haag
Managing Director
edxc@irthcommunications.com
866-976-4784

0 1499

Endexx to Develop Smart Glasses Based Compliance Solutions for the Cannabis Industry

Company Working With Vuzix to Develop Application Based On M3Hub ‘Seed to Sale’ Inventory Tracking and Management Platform Utilizing Vuzix’ M100 Smart Glasses

Cave Creek, AZ / ACCESSWIRE / November 5, 2014 / Endexx Corporation (OTC Pink: EDXC) (EDXC), a provider of innovative medical marijuana management and technology solutions (m3hub), announced today that it has signed agreements with Vuzix Corporation (VUZI) with the intention to create and complement a compliance based solution for the cannabis industry with an application for its Smart Glasses. The application will be developed based on Endexx’s m3hub “Seed to Sale” inventory tracking and management platform and will integrate with the system for full optimization. This collaboration addresses an estimated $1.5 billion medical marijuana market that is rapidly growing and forecasted to rise to $5 billion by 2016. The application is currently in the initial testing phase.

Vuzix is a leading supplier of Video Eyewear and Smart Glasses products in the enterprise, consumer, commercial, and entrainment markets. The Vuzix M100 Smart Glasses are the world’s first commercially available hands free display and wearable computer designed for enterprise users. The M100 contains a virtual display with an integrated camera and a powerful processing engine, running Android(R) to wirelessly connect via Bluetooth or WiFi directly to most standard networks or to a smartphone or other compatible device and the M100 is compatible with iOS devices such as the iPhone and iPad. The M100 is designed to run applications in standalone operation or connected to the internet, and works with thousands of existing applications. Vuzix M100 is being put to work in the enterprise markets by giants like SAP and Lenovo, the world’s largest PC vendor, along with many other leading companies.

Medical marijuana is not a new market but a developing one and since legalization has evolved into a billion dollar market. The medical marijuana space is maturing and transforming into an acceptable and lucrative business. Assurance that producers and distributors are compliant is key to developing and maintaining both compliance with regulations and integrity in the marketplace. Nationwide, there are over 2.5 million registered medical marijuana patients.

Endexx’s m3hub platform is the first standardized industry tracking platform for the medical marijuana industry that is adaptable to maintain compliance with the laws of state and local regulatory bodies and provides oversight capability to local administrative and enforcement divisions. The “Seed to Sale” process brings pharmaceutical grade compliance and standardized technology solutions through integrated services and products. The easy to use Cloud based “Seed to Sale” inventory tracking and management platform for the marijuana industry increases business workflow and tracks the supply chain, provides CRM, automation, geo synchronization, sales management, merchant processing, inventory control, quality assurance, compliance support, complex retail and medical POS integration. M3Hub generates manifests, reports, physician, patient and client management in a highly secure HIPAA-compliant cloud based environment.

Endexx’s custom made application for Vuzix’ M100 Smart Glasses will integrate with the m3hub and sync with the processing of inventory, tracking, merchant processing and in other areas that it is needed. The mixture of the m3hub and the M100 is a revolutionary way of doing business, which will cut costs for retailers and merchants while maintaining the highest compliance standards in the industry. The collaboration will streamline the medical marijuana space and maximize an already efficient system. The application will also work with Endexx’s AutoSpense(TM) and M3 Mini(TM), which are industrial grade automated inventory control and dispensing solutions that improve profitability, accountability, security and customer satisfaction. In addition, these solutions will increase productivity and reduce costs for marijuana retailers, while enhancing the quality of their service by drastically reducing transaction time for customers.

“We are very excited to work with Endexx and bring about a new solution to a booming industry that is in need of technology improvements and tools to maintain compliance standards,” said Paul Travers, President and CEO of Vuzix. “The m3hub is the ideal solution for retailers and medical practices. Our collaboration will help create better efficiencies in a very lucrative market.”

“We look forward to fully integrating this new compliance solution into our m3hub,” said Todd Davis, Founder and CEO of Endexx Corporation. “Working with the Vuzix team and wearable technology is creating cutting-edge solutions and improvement to our existing “Seed to Sale” platform. The medical marijuana industry is highly regulated and compliance is especially critical. With implementation of the Smart Glasses and our proprietary application, it will set us even further apart from other companies and put as at the forefront of the industry. As we look to develop our infused edibles or Cannsumables((TM), we also will rely more heavily on the technology that Vuzix has created.”

About Vuzix Corporation

Vuzix is a leading supplier of Video Eyewear and Smart Glasses products in the consumer, commercial and entertainment markets. The Company’s products include personal display and wearable computing devices that offer users a portable high quality viewing experience, provide solutions for mobility, wearable displays and virtual and augmented reality. Vuzix holds 39 patents and 10 additional patents pending and numerous IP licenses in the Video Eyewear field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2014 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (VUZI.QB) with offices in Rochester, NY, Oxford, UK and Tokyo, Japan.

About Endexx

Endexx provides innovative medical marijuana management and technology solutions. The company has two products that launched in the first half of 2014 – the m3hub and the Autospense(TM). Both products provide essential solutions to promote regulatory compliance and full accountability through “Seed to Sale” inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub database is the first standardized software platform for tracking pharmaceutical grade marijuana to support a Centralized Medical Marijuana Industry Repository and maintain compliance with the laws of the federal government and state and local regulatory bodies. The Autospense(TM) is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense(TM) increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers.www.endexx.com, www.m3hub.com, www.autospense.com.

Safe Harbor Notice

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

CONTACT:

For further investor and media information, contact:

Endexx Corporation
Todd Davis, Chairman & CEO
endexx@endexx.com
480-595-6900

IRTH Communications
Robert Haag
Managing Director
edxc@irthcommunications.com
866-976-4784

SOURCE: Endexx Corporation

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements